A standard, before a science.

Most of what is sold as medical cannabis was originally designed for a recreational market and adapted afterwards. Phant was built the other way around. Before we extracted a single batch, we committed to Health Canada Good Manufacturing and Good Production Practice, GACP-certified inputs, full release testing on every batch, and documented batch records for every step from intake to landed market. The portfolio exists to express that standard, not to chase it. The result is a smaller, slower catalogue than a recreational-first manufacturer would build. We think that is the right trade.

The centre of the Phant portfolio is solventless cannabis flower extract — Resinous Organic Extract (R.O.E.), three-stage ice-water concentrate, and the Afghan series. These are the formats where input quality is most legible in the finished product, and where the absence of solvents is most clinically defensible. Around that centre we have built a smaller set of formulated extracts, live resin and distillate cartridges, an oral cannabis oil, and bulk supply for licensed manufacturers in markets where local finishing is required. Every format carries a Certificate of Analysis covering cannabinoids, terpenes, microbiology, mycotoxins, heavy metals, residual solvents, and pesticide residues. We do not release product that fails any specification.

Phant supplies the United Kingdom, Germany, the Czech Republic, South Africa, and Australia through licensed medical channels. The United Kingdom is currently the largest of those markets and the one we treat as our domestic clinical market. Across all five jurisdictions the manufacturing standard is identical; what changes is the regulatory paperwork attached to release. We work with importers, medical distributors, and procurement teams who operate inside their local regulatory framework. We do not supply patients directly.

The site you are reading was built for the people who actually carry the clinical and procurement responsibility — prescribers, pharmacists, licensed distributors, and the patients researching what is being prescribed to them. Every product page carries the cannabinoid and terpene data, the manufacturing method, the format, the packaging, and a reference lot. Certificates of Analysis are available on request. Prescriber briefs are available on request. We are deliberately quiet on most of the things a recreational brand would be loud about. That is the point.